首页> 美国卫生研究院文献>Cell Transplantation >Additional Use of Synovial Mesenchymal Stem Cell Transplantation FollowingSurgical Repair of a Complex Degenerative Tear of the Medial Meniscus of the Knee: A CaseReport
【2h】

Additional Use of Synovial Mesenchymal Stem Cell Transplantation FollowingSurgical Repair of a Complex Degenerative Tear of the Medial Meniscus of the Knee: A CaseReport

机译:滑膜间充质干细胞移植后的其他用途膝内侧半月板的复杂退化性撕裂的外科修复:一例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Complex degenerative tears of the medial meniscus in the knee are usually treated using meniscectomy. However, this procedure increases the risk of osteoarthritis, while other treatments aimed at meniscal repair remain challenging due to the high possibility of failure. The use of synovial mesenchymal stem cells (MSCs) is an attractive additional approach for meniscal repair, as these cells have high proliferative and chondrogenic potential. In this case report, we surgically repaired a complex degenerative tear of the medial meniscus and then transplanted autologous synovial MSCs. We evaluated clinical outcomes at 2 years and assessed adverse events. We enrolled patients with clinical symptoms that included a feeling of instability in addition to pain caused by their complex degenerative tears of the medial meniscus. Two weeks after surgical repair of the torn meniscus, autologous synovial MSCs were transplanted onto the menisci of five patients. The total Lysholm knee score, the Knee Injury and Osteoarthritis Outcome Scale scores for “pain,” “daily living,” “sports activities,” and the Numerical Rating Scale were significantly increased after 2 years. Three adverse events, an increase in c-reactive protein, joint effusion, and localized warmth of the knee were recorded, although these could have been due to the meniscal repair surgery. This first-in-human study confirmed that the combination of surgical repair and synovial MSC transplantationimproved the clinical symptoms in patients with a complex degenerative tear of the medialmeniscus. No adverse events occurred that necessitated treatment discontinuation. Thesefindings will serve as pilot data for a future prospective study.
机译:通常使用半月板切除术治疗膝盖内侧半月板的复杂性变性眼泪。然而,这种方法增加了骨关节炎的风险,而其他针对半月板修复的治疗由于失败的可能性很高而仍然具有挑战性。滑膜间充质干细胞(MSCs)的使用是用于半月板修复的一种有吸引力的附加方法,因为这些细胞具有很高的增殖和软骨形成潜能。在此病例报告中,我们通过手术修复了内侧半月板的复杂性变性撕裂,然后移植了自体滑膜MSC。我们评估了2年的临床结局并评估了不良事件。我们招募了具有临床症状的患者,这些患者除了因其复杂的内侧半月板退化性眼泪引起的疼痛外,还包括不稳定的感觉。手术修复半月板撕裂后两周,将自体滑膜MSC移植到五名患者的半月板上。 2年后,“疼痛”,“每天生活”,“体育活动”和“数字评分量表”的总Lysholm膝关节评分,膝关节损伤和骨关节炎结果量表评分显着提高。记录了三个不良事件,即c反应蛋白增加,关节积液和膝关节局部发热,尽管这些可能是由于半月板修复手术引起的。这项首次人类研究证实了手术修复和滑膜MSC移植的结合改善了复杂的内侧退行性撕裂患者的临床症状半月板。没有发生需要停止治疗的不良事件。这些研究结果将作为未来前瞻性研究的试验数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号